ВІТРЯНА ВІСПА У ДІТЕЙ (огляд літератури)

I. I. Nezgoda, L. I. Levytska

Анотація


Мета роботи – на підставі літературних відо-
мостей виділити особливості вітряної віспи у дітей.

Вітряна віспа є однією з найбільш розповсюджених хвороб дитячого віку. Представлені етіологія, патогенез, клінічні прояви, ускладнення, лікування та профілактика вітряної віспи. В роботі був проведений аналіз вітряної віспи, а саме особливості патогенезу, клініки та ускладнень вітряної віспи, враховуючи сучасний стан проблеми для подальшого вивчення патогенетичного перебігу хвороби у дітей і можливих методів профілактики та корекції ускладнень. 

 


Ключові слова


вітряна віспа; VZV; діти; патогенез; перебіг; клініка; ускладнення; лікування.

Повний текст:

тут

Посилання


Kramarev, S.A. (2011). Osobennosti sovremennogo techenija vetrjanoі ospy u deteі [Features of the current flow of chickenpox in children]. Dytyachyу likar, 6 (13), 1-4. [in Russian].

Popesku, C.P., Ceausu E. (2016). Complication of varicella in unvaccinated children from Romania, 2002-2013. Pediatr. Infect. Dis., 35(2), 211-212.

Reynolds, M.A., Watson, B.M., Plott-Adams, K.K. (2008). Epidemiology of Varicella Hospitalizations in the United States, 1995-2005. J. Infect. Dis. 197(2), S120-S126. doi: 10.1086/522146

Mallet, E., Maitre, M., Delalande-Dutilleul, L., Marguet, C., Mouterde O. (2004). Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France. Arch. Pediatr., 11, 1145-1151. DOI: 10.1016/j.arcped.2004.07.002

Baranov, A.A., Namazova-Baranova, L.S., Tatochenko, V.K. (2010). Nauchnoe obosnovanie vakcinacii deteiі s otklonenijami v sostojanii zdorovja [Scientific basis for vaccination of children with disabilities in the state of health] Pediatricheskaja farmakologija, 7(2), S. 6-25. [ in Russian].

Beіkin, Ya.B, Bogdanova, L.V., Lagereva, U.G. (2010). Tip immunnoі adaptacii u deteі doshkolnogo vozrasta 2 gruppy zdorovja [Type of immune adaptation in preschool children of the 2nd group of health]. Uralskiі medicinskiі zhurnal, 6, 56-60. [in Russian].

Prokopiv, O.V., Prykuda, N.M., Zadorozhnyy, A.M. (2016). Suchasnyy stan zakhvoryuvanosti na vitryanu vispu v ditey za materialamy Lvivskoyi oblasti [The current state of the incidence of chickenpox in children on the materials of Lviv region]. Klinichna ta eksperymental'na patolohiya, XV, (2. 1.), 134-137 [in Ukrainian].

Arvin, A.M.( 2002). Antiviral therapy for varicella and herpes zoster. Pediatr. Infect. Dis. 13(1), 12-21.

Koturoglu, G., Kurugöl, Z., Cetin, N., Hizarcioglu, M., Vardar, F., Helvaci, M. & Ozkinay, C. (2005). Complications of varicella in healthy children in Izmir, Turkey. Pediatr. Int. 47(3), 296-299. DOI: 10.1111/j.1442-200x.2005.02054.x

Varicella and herpes zoster vaccines: WHO position paper. (2014 Jun 20). Wkly Epidemiol Rec., 89(25), 265-288.

Skripchenko, N.V., Ivanova, G.P., Komancev V.N. (2009). Sovremennye osobennosti vetrjanochnyh encefalitov u deteі [Modern features of varicella encephalitis in children]. Zhurnal infektologii, 1( 4), 36-44 [in Russian].

Ermolenko, M.V. (2014). Serologicheskiiі monitoring v sisteme jepidemiologicheskogo nadzora za vetrjanoĭ ospoĭ (dis. ... kand. med. nauk) [Serological monitoring in the system of epidemiological surveillance of varicella]. (Candidate's thesis). Moscow, 103 p. [in Russian].

Ramachandra, S., Arun Kumar Metta, Nayeem Sadath Haneef, Sandeep Kodali (2010). Fetal varicella syndrome. Indian J. Dermatol. Venereol. Leprol., 76(6), 724. DOI: 10.4103/0378-6323.72475

Leuridan, E., Hens, N., Hutse, V. (2011). Kinetics of maternal antibodies against rubella and varicella in infants. Vaccine. 29(11), 2222-2226.

Chernyshova, L.I., Volokha, A.P. (2013). Dytyacha imunolohiya [Pediatric Immunology]. Kyiv, 488-492 [in Ukrainian].

Duda, O.K., Veha, A.R. (2014). Vitryana vispa: aktual'ni pytannya i mozhlyvosti. [Chickenpox: issues and opportunities]. Semeynaya medytsyna, 3(53), 143-148 [in Ukrainian].

Dyeyev, V.V. (2015). Vitryana vispa u ditey: osoblyvosti patohenezu, kliniky, likuvannya (dys. ... kand. med. nauk) [Chickenpox in children: peculiarities of pathogenesis, clinical manifestations, treatment]. (Candidate's thesis). Kyiv, 113 p. [in Ukrainian].

Chuklin, S.N., Perejaslov, A.A. (2005). Interleіkiny. [Interleukins]. Lvov, 481 p. [in Russian].

Vossen, M.T., Biezeveld, M.H, de Jong M.D. (2005). Absence of circulating natural killer and primed CD8+ cells in life-threatening varicella. J. Infect. Dis., 191(2), 198-206.

Arvin, A.M. (2008). Humoral and cellular immunity to varicella-zoster virus: an overview. J. Infect. Dis. 197(2), S58-S60. DOI: https://doi.org/10.1086/522123

Arvin, A.M. (1996). Immune responses to varicella-zoster virus. Infect. Dis. Clin. North. Am. 10(3), 529-570.

Park, H.B., Kim, K.C., Park, J.H., Kang, T.Y., Lee, H.S., Kim, T.H. & Jung, S. (2004). Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J. Rheumatol. 31(11), 2151-2155. PMID: 15517626

Liese, J.G., Grote, V., Rosenfeld, E., Fischer, R., Belohradsky, B.H., Rüdiger v Kries. (2008). The burden of varicella complications before the introduction of routine varicella vaccination in Germany. ESPED Varicella Study Group. Pediatr. Infect. Dis. J. 27(2), 119-124. DOI:10.1097/INF.0b013e3181586665

Torigo, S., Ihara, T., Kamiya, H. (2000). IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol. Immunol. 44(12), 1027-1031. PMID: 11220676

Dyeyev, V.V. (2013). Vitryana vispa u diteі v suchasnykh umovakh: osoblyvosti klinichnoho perebihu, interferonovyу, tsytokinovyу status [Chickenpox in children under current conditions, clinical course, interferon, cytokine status] Problemy viуskovoі okhorony zdorovya: zbirnyk naukovykh prats Ukraіnskoі viуskovo-medychnoі akademiі, 39, 99-108 [in Ukrainian].

Askalan, R., Laughlin, S., Mayank, S., Chan, A., MacGregor, D., Andrew, M. & deVeber, G. (2001). Chickenpox and stroke in childhood: a study of frequency and causation. Stroke (32), 1257-1262.

Askalan, R., Marjoke Verweij. (2008). Vascular complication of Varicella. Pediatr. Infect. Dis. 34(11), 1256-1259.

Yushchuk, N.D., Astafeva, N.V., Bіkova, R.N. (2000). Vetryanaya ospa u vzroslіkh [Chicken pox in adults]. Lechashchyу vrach, 1, 40-43 [in Russian].

Nagel, M.A., Cohrs, R.J., Mahalingam, R, Wellish, M.C., Forghani, B., Schiller, A. & Gilden, D.H. (2008).The varicella zoster virus vasculopathies: clinical, CSF imaging and virologic features. Neurology, 70, 853-860. doi: 10.1212/01.wnl.0000304747.38502.e8.

Nagel, M.A. (2014). Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol. 20(2), 157-163. doi: 10.1007/s13365-013-0183-9

Ataullakhanov, R.Y., Hyntsburh, A.L. (2005). Ymmunytet y ynfektsyya: dynamychnoe protyvostoyanye zhyvіkh system [Immunity and infection: a dynamic confrontation of living systems] Pedyatryya, 4(8), 47-61 [ in Russian].

Mueller, N.H., Gilden, D.H., Cohrs, R.J., Mahalingam, R., Nagel, M.A. (2008). Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol. Clin. 26(3), 675-697. DOI: 10.1016/j.ncl.2008.03.011

Ceroni, A., Sibani, S., Baiker, A., Pothineni, Venkata Raveendra, Bailer, S.M., Joshua Labaer, & Campbell, C.J. (2010). Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray. Mol. Biosyst. 6(9), 1604-1610. DOI: 10.1039/c003798b

Roіt, A., Brostoff, Dzh., Meуl, D. (2000). Ymmunolohyya: Per. s anhl. [Immunology]. 592 p. [in Russian].

Loskutova, I.V. (2006). Vplyv antralyu ta amizonu na interferonohenez u khvorykh na tyazhki ta uskladneni formy vitryanoyi vispy [Impact Antral and amisone interferonohenez in patients with severe and complicated forms of varicella]. Ukrayins'kyy medychnyy al'manakh. 1, 12-14. [in Ukrainian].

Kramarov, S.O., Vyhovska, O.V., Deev, V.V., Humenyuk, V.B., Danylyuk, O.V., Bakaу, K.V. & Kuznets, O.A. (2015). Uskladnennya vitryanoyi vispy u ditey v suchasnykh umovakh [Complications of chickenpox in children in modern]. Problemy viyskovoyi okhorony zdorovya. Zbirnyk naukovykh prats' Ukrayinskoyi viyskovo-medychnoyi akademiyi. 44(2), 184-192. [in Ukrainian].

Tatochenko, V.K., Ksenofontova, O.L., Rozhkova L.V. (2010). Postеkspozytsyonnaya ymmunoprofylaktyka vetryanoу ospі [Postexpositional immunoprophylaxis of chicken pox]. Pedyatrycheskaya farmakolohyya. 7(4), 30-33. [in Russian].

Breuer, J., Whitley, R. (2007). Varicella zoster virus: natural history and current therapies of varicella and herpes zoster. Herpes. 14(2), 25-29.

Hernández Blanco, A., González Montero, R., Urán Moreno, M.M. (2009). Post-varicella purpura fulminans: potentially fatal. An. Pediatr. (Bare), 70(4), 379-382. doi:10.1016/j.anpedi.2008.11.018

Makarova, A.V., Demchenkov, V.V., Bolіsheva, H.S. (2009). Vyrusnіе еntsefalіtі u deteі [Viral encephalitis in children]. Zhurnal ynfektolohyy. Prylozhenye. 1(2), 43. [ in Russian].

Wiegering, V., Schick, J., Beer, M., Weissbrich, B., Gattenlöhner, S., Girschick, H.J. & Eyrich M. (2011). Varicella-zoster virus infections in immunocompromised patients – a single centre 6-year analysis. Abstract. BMC Pediatr. 11(1), 31. DOI: 10.1186/1471-2431-11-31

Malavige, G.N., Jones, L., Kamaladasa, S.D., Wijewickrama, A., Seneviratne, S.L., et al. (2008) Viral Load, Clinical Disease Severity and Cellular Immune Responses in Primary Varicella Zoster Virus Infection in Sri Lanka. PLoS ONE, 3(11): e3789. doi:10.1371/journal.pone.0003789

Sorokina, M.N., Skripchenko, N.V. (2004). Virusnye encefalitі i meningitі u deteі [Viral encephalitis and meningitis in children]. Moscow, 416 p. [ in Russian].

Cohrs, R.J., Gilden, D.H. (2010). Molecular Characterization of Varicella Zoster Virus in Latently Infected Human Ganglia: Physical State and Abundance of VZV DNA, Quantitation of Viral Transcripts and Detection of VZV-Specific Proteins Curr Top Microbiol Immunol. 342, 229–241. doi: 10.1007/82_2009_2

Kleinschmidt-DeMasters, B.K., Gilden, D.H. (2001). Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch. Pathol. Lab. Med. 125(6), 770-780. DOI: 10.1043/0003-9985(2001)125<0770:VZVIOT>2.0.CO;2

Baskin, H.J. & Hedlund, G. (2007). Neuroimaging of herpesvirus infections in children. Pediatr. Radiol. 37, 949-963. http://dx.doi.org/10.1007/s00247-007-0506-1

Wallace, M.R., Woelfl, I., Bowler, W.A. (1994). Tumor necrosis factor, interleukin-2, and interferon-gamma in adult varicella. J. Med. Virol. 43, 69-71.

Abendroth, A., Morrow, G., Cunningham, A.L. & Slobedman, B. (2001). Varicella-zoster virus infection of human dendritic cells and transmission to T cells: Implications for virus dissemination in the host. J. Virol., 75, 6183-6192.

Prokopiv, O.V., Prykuda, N.M. (2012). Pohlynalna zdatnist ta metabolichna aktyvnist neytrofilnykh fahotsytiv pry bakterialnykh uskladnennyakh u ditey [Absorbtion ability and metabolic activity of neutrophilic phagocytosis in bacterial confinement in children]. Praktychna medytsyna, 2 (XVIII), 68-74. [in Ukrainian].

Raulin, O., Durand, G., Gillet, Y., Bes, M., Lina, G., Vandenesch, F., & Laurent, F. (2010). Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection J. Clin. Microbiol., 48(5), 1696-1700. doi:10.1128/JCM.02018-09

Hervas, D., Henales, V., Yeste, S. (2011). How frequent is varicella-associated pneumonia in children? Eur. J. Clin. Microbiol. Infect. Dis., 30(3), 435-437.

Mikaeloff, Y., Kezouh, A., Suissa, S. (2008). Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br. J. Clin. Pharmacol., 65(2), 203-209. doi: 10.1111/j.1365-2125.2007.02997.x

Cameron, J.C., Allan, G., Johnston, F., Finn, A., Heath, P.T. and Booy R. (2007). Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch. Dis. Child., 92(12), 1062-1066. doi: 10.1136/adc.2007.123232

Gnann J.W.Jr. (2002). Varicella-zoster virus: atypical presentations and unusual complications. J. Infect. Dis., 186(1), 91-98.

Rack, A.L., Grote, V., Streng, A., Belohradsky, B.H., Heinen, F., von Kries, R., & Liese J.G. (2010). Neurologic varicella complications before routine immunization in Germany. Pediatr. Neurol. 42(1), 40-48. DOI: 10.1016/j.pediatrneurol.2009.07.012

Ksenofontova, O.L. (2002). Kliniko-immunologicheskie zakonomernosti i optimizacija lechenija vetrjanoĭі ospy u deteі (dis. ... kand. med. nauk) [Clinical and immunological regularities and optimization. Treatment of varicella in children] (Candidate's thesis). Ekaterinburg, 121 p. [in Russian].

Harris, D., Redhead, J. (2005). Should acyclovir be prescribed for immunocompetent children pre-senting with chickenpox? Arch. Dis. Child., 90(6), 648-650.

Romanenko, T.A., Lyhina, Yu.A. (2013). Dosvid vaktsynoprofilaktyky vitryanoyi vispy v krayinakh svitu [Experience varicella vaccine in countries ] Profilaktychna medytsyna, 1–2 (20), 44 – 49. [in Ukrainian].

Hirose, M., Gilio, A.E., Esposito Ferronato, A., Lopes Betta Ragazzi, S. (2016). The impact of varicella vaccination on varicella-related hospitalization rates: global data review. Rev. Paul Pediatr., 34(3), 359-366.

Nakaz 11.08.2014 № 551 Pro udoskonalennya provedennya profilaktychnykh shcheplen v Ukrayini [Order of 11.08.2014 number 551 on improving preventive vaccinations in Ukraine] [Elektronnyy resurs]. – Rezhym dostupu: http://zakon3.rada.gov.ua/laws/show/z1237-14/paran2#n2 [in Ukrainian].




DOI: http://dx.doi.org/10.11603/1681-2727.2017.1.7786

Посилання

  • Поки немає зовнішніх посилань.